Interview with Professor Matthias P. Lütolf on progress in organoid technology, how the technology is being used in pharmaceutical research and the Institute of Human Biology

Matthias P. Lütolf is founding director and Head of Translational Bioengineering at Roche’s Institute of Human Biology (IHB) and Professor of Bioengineering at EPFL. His research focuses on the use of state-of-the-art bioengineering strategies to steer stem cell-based development in such a way as to construct novel organoids with improved reproducibility and greater physiological relevance for basic research and real-world applications in medicines research and development.